Literature DB >> 6502194

Local blood flow in Walker 256 metastatic brain tumors.

R G Blasberg, W R Shapiro, P Molnar, C S Patlak, J D Fenstermacher.   

Abstract

Local blood flow (F) in metastatic Walker 256 (WL-256) brain tumors produced by the intracarotid artery injection of WL-256 tumor cells in rats was measured using 14C-iodoantipyrine and quantitative autoradiography. Blood flow was variable in the tumors; the overall range was 2 to 222 ml hg-1 min-1 and the maximum range in an individual tumor extended over 150 ml hg-1 min-1. Small tumors had mean blood flows similar to surrounding brain. Medium to large tumors had significantly lower flows; the lowest values were usually measured in necrotic or cystic regions, although low values (less than 20 ml hg-1) were also measured in some viable-appearing tumor regions. Blood flow was significantly reduced in brain adjacent to medium and large but not small tumors. A global depression of brain and tumor blood flow was measured in two animals with hydrocephalus and the largest tumor burden. The blood flow patterns of the WL-256 metastatic tumor model are not uniquely different from other brain tumor models although some individual differences exist.

Entities:  

Mesh:

Year:  1984        PMID: 6502194     DOI: 10.1007/bf00253271

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  The theory and applications of the exchange of inert gas at the lungs and tissues.

Authors:  S S KETY
Journal:  Pharmacol Rev       Date:  1951-03       Impact factor: 25.468

2.  Proceedings: Tumor angiogenesis factor.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

3.  Permeability limitation in estimation of local brain blood flow with [14C]antipyrine.

Authors:  W W Eckman; R D Phair; J D Fenstermacher; C S Patlak; C Kennedy; L Sokoloff
Journal:  Am J Physiol       Date:  1975-07

4.  Regional blood flow and blood-to-tissue transport in five brain tumor models. Implications for chemotherapy.

Authors:  D R Groothuis; P Molnar; R G Blasberg
Journal:  Prog Exp Tumor Res       Date:  1984

5.  Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group.

Authors:  B Borgelt; R Gelber; M Larson; F Hendrickson; T Griffin; R Roth
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-12       Impact factor: 7.038

6.  Regional differences in the growth of normal and neoplastic cells.

Authors:  R Auerbach; W Auerbach
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

7.  Measurement of local cerebral blood flow with iodo [14C] antipyrine.

Authors:  O Sakurada; C Kennedy; J Jehle; J D Brown; G L Carbin; L Sokoloff
Journal:  Am J Physiol       Date:  1978-01

8.  Regional blood flow in ethylnitrosourea-induced brain tumors.

Authors:  R G Blasberg; T Kobayashi; M Horowitz; J M Rice; D Groothuis; P Molnar; J D Fenstermacher
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

9.  Local blood-to-tissue transport in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; W R Shapiro; P Molnar; C S Patlak; J D Fenstermacher
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

10.  Radiation therapy for brain metastases.

Authors:  J G Cairncross; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1980-06       Impact factor: 10.422

View more
  11 in total

1.  Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats.

Authors:  M G Kaplitt; J G Tjuvajev; D A Leib; J Berk; K D Pettigrew; J B Posner; D W Pfaff; S D Rabkin; R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Noisy intracranial tumours.

Authors:  B T van Dooren; A C van Bruggen; J J Mooij; J M Hew; H L Journée
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study.

Authors:  T Siegal; U Sandbank; A Gabizon; T Siegal; R Mizrachi; E Ben-David; R Catane
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Apparent glucose utilization in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; M Shinohara; W R Shapiro; C S Patlak; K D Pettigrew; J D Fenstermacher
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

5.  Local blood-to-tissue transport in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; W R Shapiro; P Molnar; C S Patlak; J D Fenstermacher
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

6.  Growth activity of tumors at different intracranial structures: immunohistochemical study with bromodeoxyuridine.

Authors:  T Yoshimine; Y Ushio; T Hayakawa; O Takemoto; M Maruno; H Mogami
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

Review 7.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

Authors:  R D Fross; P C Warnke; D R Groothuis
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

8.  Apparent glucose utilization in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; M Shinohara; W R Shapiro; C S Patlak; K D Pettigrew; J D Fenstermacher
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 9.  The quest for a better insight into physiology of fluids and barriers of the brain: the exemplary career of Joseph D. Fenstermacher.

Authors:  Adam Chodobski; Jean-François Ghersi-Egea; Charles Nicholson; Tavarekere N Nagaraja; Joanna Szmydynger-Chodobska
Journal:  Fluids Barriers CNS       Date:  2015-01-12

10.  Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours.

Authors:  Kate M Lewis; Elizabeth Harford-Wright; Robert Vink; Mounir N Ghabriel
Journal:  Cancer Cell Int       Date:  2013-02-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.